JCR Pharmaceuticals Co., Ltd.
Symbool: JCRRF
PNK
6.2
USDMarktprijs vandaag
18.8882
Koers/Winst Verhouding
-0.0016
Koers/Winst Groei Verhouding
773.77M
MRK Kapitalisatie
- 0.00%
DIV Rendement
JCR Pharmaceuticals Co., Ltd. (JCRRF) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 13278 | 30977 | 26260 | |||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | -214 | 244 | -225 | |||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 11137 | 15585 | 8183 | |||||||||||||||||||
balance-sheet.row.inventory | 0 | 18514 | 14636 | 13554 | |||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 4873 | 990 | 548 | |||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 47802 | 62188 | 48545 | |||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 32681 | 26782 | 17172 | |||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 3652 | 2960 | 3232 | |||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 3652 | 2960 | 3232 | |||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 9081 | 1986 | 2797 | |||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 1357 | 2433 | 1739 | |||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 362 | 783 | 296 | |||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 47133 | 34944 | 25236 | |||||||||||||||||||
balance-sheet.row.other-assets | 0 | 2 | 2 | 3 | |||||||||||||||||||
balance-sheet.row.total-assets | 0 | 94937 | 97134 | 73784 | |||||||||||||||||||
balance-sheet.row.account-payables | 0 | 1563 | 1324 | 2932 | |||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 17300 | 15150 | 12850 | |||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 33 | 5915 | 2646 | |||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 5500 | 2950 | 5250 | |||||||||||||||||||
Deferred Revenue Non Current | 0 | -428 | -343 | -378 | |||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 12975 | 13472 | 9687 | |||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 6763 | 3994 | 6203 | |||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 73 | 44 | 42 | |||||||||||||||||||
balance-sheet.row.total-liab | 0 | 42525 | 46048 | 35231 | |||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.common-stock | 0 | 9061 | 9061 | 9061 | |||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 34273 | 33241 | 20904 | |||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1421 | 1184 | 1159 | |||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 7406 | 7395 | 7255 | |||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 52161 | 50881 | 38379 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 94937 | 97134 | 73784 | |||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 251 | 205 | 174 | |||||||||||||||||||
balance-sheet.row.total-equity | 0 | 52412 | 51086 | 38553 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||
Total Investments | 0 | 8867 | 2230 | 2572 | |||||||||||||||||||
balance-sheet.row.total-debt | 0 | 22800 | 18100 | 18100 | |||||||||||||||||||
balance-sheet.row.net-debt | 0 | 9522 | -12633 | -8160 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 5412 | 19404 | 8653 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1997 | 1945 | 1892 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -9221 | -3074 | -983 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 173 | 177 | 149 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -2956 | -9030 | 323 | |||||||||||||||||||
cash-flows.row.account-receivables | 0 | 3269 | -7501 | -204 | |||||||||||||||||||
cash-flows.row.inventory | 0 | -3877 | -1082 | -4699 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | 238 | -1608 | 2253 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -2586 | 1161 | 2973 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -905 | -133 | 307 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -8560 | -11333 | -7527 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -6717 | 8167 | -2747 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -906 | -300 | -391 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 259 | 300 | 584 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 922 | -84 | 6791 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -15002 | -3250 | -3290 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -3050 | -750 | -650 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 10 | 10 | 13 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -10 | -10 | -13 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -2739 | -2169 | -1083 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 7737 | 740 | 10037 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 1948 | -2179 | 8304 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 1099 | 612 | -22 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -17455 | 4473 | 15332 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 13278 | 30733 | 26260 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 30733 | 26260 | 10928 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -5500 | 9289 | 10341 | |||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -8560 | -11333 | -7527 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -14060 | -2044 | 2814 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 34343 | 51082 | 30085 | |||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 8886 | 10461 | 7812 | |||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 25457 | 40621 | 22273 | |||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 58 | 38 | 61 | |||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 20480 | 20686 | 14003 | |||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 29366 | 31147 | 21815 | |||||||||||||||||||
income-statement-row.row.interest-income | 0 | 33 | 7 | 7 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 44 | 45 | 42 | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 437 | -529 | 384 | |||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 58 | 38 | 61 | |||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 437 | -529 | 384 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 44 | 45 | 42 | |||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1997 | 1945 | 1892 | |||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.operating-income | 0 | 4975 | 19933 | 8269 | |||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 5412 | 19404 | 8653 | |||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 1625 | 4886 | 1764 | |||||||||||||||||||
income-statement-row.row.net-income | 0 | 3772 | 14507 | 6892 |
Vaak gestelde vragen
Wat is JCR Pharmaceuticals Co., Ltd. (JCRRF) totale activa?
JCR Pharmaceuticals Co., Ltd. (JCRRF) totale activa is 94937000000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.748.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.130.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.189.
Wat is JCR Pharmaceuticals Co., Ltd. (JCRRF) nettowinst (netto-inkomen)?
De nettowinst is 3772000000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 22800000000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 20480000000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.